ArticleACS omega2025
MulAFNet: Integrating Multiple Molecular Representations for Enhanced Property Prediction.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MolProphecy: Bridging medicinal chemists' knowledge and molecular pre-trained models via a multi-modal framework.Journal of advanced research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In computer-aided drug design, molecular representation plays a crucial role. Most existing multimodal approaches primarily perform simple concatenation of various feature representations, without adequately emphasizing effective integration among these features. To address this issue, this study proposes a network framework that integrates multimodal representations using a multihead attention flow (MulAFNet). MulAFNet utilizes SMILES string representation and two levels of molecular graph representations: atom-level and functional group-level graph structure. Pretraining tasks are established for each of these three representations, which are then fused in downstream tasks to predict molecular properties. The experiments were conducted on six classification data sets and three regression data sets, demonstrating that the use of multiple molecular representations as input has a significant impact on the results. In particular, the excellent performance of our fusion method in molecular property prediction outperforms other state-of-the-art methods, proving its superiority. Additionally, comparative experiments on fusion methods and ablation studies, further validate the effectiveness of MulAFNet. The results demonstrate that multiple molecular feature representations provide a more comprehensive molecular understanding, and appropriate pretraining tasks enhance molecular property prediction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.